732 related articles for article (PubMed ID: 31276706)
41. Soft tissue sarcoma in adults.
Dirix LY; Van Oosterom AT
Curr Opin Oncol; 1999 Jul; 11(4):285-95. PubMed ID: 10416881
[TBL] [Abstract][Full Text] [Related]
42. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
43. Genetic and molecular abnormalities in tumors of the bone and soft tissues.
Letson GD; Muro-Cacho CA
Cancer Control; 2001; 8(3):239-51. PubMed ID: 11378650
[TBL] [Abstract][Full Text] [Related]
44. A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma.
Herold N
Cancer Gene Ther; 2024 Jun; 31(6):805-806. PubMed ID: 38409586
[TBL] [Abstract][Full Text] [Related]
45. Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.
Tang F; Min L; Seebacher NA; Li X; Zhou Y; Hornicek FJ; Wei Y; Tu C; Duan Z
J Orthop Res; 2019 Mar; 37(3):789-798. PubMed ID: 30667081
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
47. Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas.
Joseph CG; Hwang H; Jiao Y; Wood LD; Kinde I; Wu J; Mandahl N; Luo J; Hruban RH; Diaz LA; He TC; Vogelstein B; Kinzler KW; Mertens F; Papadopoulos N
Genes Chromosomes Cancer; 2014 Jan; 53(1):15-24. PubMed ID: 24190505
[TBL] [Abstract][Full Text] [Related]
48. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract][Full Text] [Related]
49. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
Willeke F
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
[TBL] [Abstract][Full Text] [Related]
50. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract][Full Text] [Related]
51. Molecular alterations in bone and soft-tissue sarcoma.
Bell RS; Wunder J; Andrulis I
Can J Surg; 1999 Aug; 42(4):259-66. PubMed ID: 10459325
[TBL] [Abstract][Full Text] [Related]
52. Loss of TP53 in sarcomas with 17p12 to approximately p11 gain. A fine-resolution oligonucleotide array comparative genomic hybridization study.
Kaur S; Larramendy ML; Vauhkonen H; Böhling T; Knuutila S
Cytogenet Genome Res; 2007; 116(3):153-7. PubMed ID: 17317953
[TBL] [Abstract][Full Text] [Related]
53. Histologic and Immunohistochemical Analyses of Soft Tissue Sarcomas From brca2-Mutant/ tp53-Mutant Zebrafish Are Consistent With Neural Crest (Schwann Cell) Origin.
White LA; Sexton JM; Shive HR
Vet Pathol; 2017 Mar; 54(2):320-327. PubMed ID: 27879444
[TBL] [Abstract][Full Text] [Related]
54. Sarcoma.
Skubitz KM; D'Adamo DR
Mayo Clin Proc; 2007 Nov; 82(11):1409-32. PubMed ID: 17976362
[TBL] [Abstract][Full Text] [Related]
55. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
56. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
57. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
58. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
59. TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma.
Casey DL; Pitter KL; Wexler LH; Slotkin EK; Gupta GP; Wolden SL
Br J Cancer; 2021 Aug; 125(4):576-581. PubMed ID: 34017087
[TBL] [Abstract][Full Text] [Related]
60. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
